{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T20:56:07Z","timestamp":1786827367394,"version":"build-2736575974"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Sublingual haematoma is a rare complication of anticoagulants and can be life-threatening. As the number of prescribed anticoagulants is increasing, the incidence of complications of these drugs will continue to increase. A report of a sublingual haematoma in an elderly patient with chronic atrial fibrillation treated with edoxban (Lixiana \u00a9, Daiichi Sankyo Europe GmbH, M\u00fcnchen, Germany) is reported. A 90-year male presented at the emergency department with an obstructed upper airway due to a sublingual haematoma. The patient received tranexamic acid, prothrombin complex, and fresh frozen plasma. After fiberoptic nasal intubation, the patient was monitored in the intensive care unit. After four days, the patient was extubated, and after six days, the swelling resolved completely. Complications of anticoagulants are rare but can be life-threatening. Recognition of an endangered airway and reversing the effects of the anticoagulant are essential. Surgical evacuation of the haematoma could be considered but is not necessary.<\/jats:p>","DOI":"10.2478\/jccm-2020-0010","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T15:57:32Z","timestamp":1590508652000},"page":"111-114","source":"Crossref","is-referenced-by-count":4,"title":["Spontaneous Sublingual Haematoma in a 90-year Old Patient: A Complication of Direct Oral Anticoagulants"],"prefix":"10.2478","volume":"6","author":[{"given":"Johannes Dani\u00ebl","family":"Cnossen","sequence":"first","affiliation":[{"name":"Ikazia Hospital Rotterdam , Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette Fenna","family":"Schoonderbeek","sequence":"additional","affiliation":[{"name":"Ikazia Hospital Rotterdam , Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Muller","sequence":"additional","affiliation":[{"name":"Ikazia Hospital Rotterdam , Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"2023122812393683331_j_jccm-2020-0010_ref_001_w2aab3b7b8b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA. 2015;314(17):1818-31.","DOI":"10.1001\/jama.2015.13766"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_002_w2aab3b7b8b1b6b1ab2b1b2Aa","unstructured":"LAREB DD. Update overview 2019 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab.: LAREB; 2019 https:\/\/databankws.lareb.nl\/Downloads\/Signals_2019_DOACs_update_overview%202019.pdf"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_003_w2aab3b7b8b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Lepore ML. Upper airway obstruction induced by warfarin sodium. Arch Otolaryngol. 1976;102(8):505-6.","DOI":"10.1001\/archotol.1976.00780130099015"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_004_w2aab3b7b8b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Gonzalez-Garcia R, Schoendorff G, Munoz-Guerra MF, Rodriguez-Campo FJ, Naval-Gias L, Sastre-Perez J. Upper airway obstruction by sublingual haematoma : a complication of anticoagulation therapy with acenocoumarol. Am J Otolaryngol. 2006;27(2):129-32.","DOI":"10.1016\/j.amjoto.2005.07.013"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_005_w2aab3b7b8b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Cashman E, Shandilya M, Amin M, Hughes J, Walsh M. Warfarin-induced sublingual haematoma mimicking Ludwig angina: Conservative management of a potentially life-threatening condition. Ear Nose Throat J. 2011;90(2):E1.","DOI":"10.1177\/014556131109000208"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_006_w2aab3b7b8b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Frohna WJ, Lowery RC, Jr., Pita F. Lingual and sublingual haematoma causing upper airway obstruction. J Emerg Med. 2012;43(6):1075-6.","DOI":"10.1016\/j.jemermed.2011.05.075"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_007_w2aab3b7b8b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Puri A, Nusrath MA, Harinathan D, Lyall J. Massive sublingual haematoma secondary to anticoagulant therapy complicated by a traumatic denture: a case report. J Med Case Rep. 2012;6:105.","DOI":"10.1186\/1752-1947-6-105"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_008_w2aab3b7b8b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Lovallo E, Patterson S, Erickson M, Chin C, Blanc P, Durrani TS. When Is \u201cPseudo-Ludwig\u2019s Angina\u201d Associated With Coagulopathy Also a \u201cPseudo\u201d Hemorrhage? J Investig Med High Impact Case Rep. 2013;1(2):2324709613492503.","DOI":"10.1177\/2324709613492503"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_009_w2aab3b7b8b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Pathak R, Supplee S, Aryal MR, Karmacharya P. Warfarin induced sublingual haematoma : a Ludwig angina mimic. Am J Otolaryngol. 2015;36(1):84-6.","DOI":"10.1016\/j.amjoto.2014.08.008"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_010_w2aab3b7b8b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Almegren M. Reversal of direct oral anticoagulants. Vasc Health Risk Manag. 2017;13:287-92.","DOI":"10.2147\/VHRM.S138890"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_011_w2aab3b7b8b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Palaiodimos L, Miles J, Kokkinidis DG, Barkolias C, Jonnalagadda AK, Papaconstantinou D, et al. Reversal of Novel Anticoagulants in Emergent Surgery and Trauma: A Comprehensive Review and Proposed Management Algorithm. Curr Pharm Des. 2018;24(38):4540-53.","DOI":"10.2174\/1381612825666181226150629"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_012_w2aab3b7b8b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014;63(20):2141-7.","DOI":"10.1016\/j.jacc.2014.02.549"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_013_w2aab3b7b8b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_014_w2aab3b7b8b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, et al. Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation. 2013;128(21):2325-32.","DOI":"10.1161\/CIRCULATIONAHA.113.002332"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_015_w2aab3b7b8b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Cowell RP. Direct oral anticoagulants: integration into clinical practice. Postgrad Med J. 2014;90(1067):529-39.","DOI":"10.1136\/postgradmedj-2013-132474"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_016_w2aab3b7b8b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, et al. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554-62.","DOI":"10.1182\/blood-2012-11-468207"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_017_w2aab3b7b8b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Greinacher A, Thiele T, Selleng K. Reversal of anticoagulants: an overview of current developments. Thromb Haemost. 2015;113(5):931-42.","DOI":"10.1160\/TH14-11-0982"},{"key":"2023122812393683331_j_jccm-2020-0010_ref_018_w2aab3b7b8b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Karmacharya P, Pathak R, Ghimire S, Shrestha P, Ghimire S, Poudel DR, et al. Upper Airway Haematoma Secondary to Warfarin Therapy: A Systematic Review of Reported Cases. N Am J Med Sci. 2015;7(11):494-502.","DOI":"10.4103\/1947-2714.170606"}],"container-title":["The Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/jccm\/6\/2\/article-p111.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/pdf\/10.2478\/jccm-2020-0010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T12:39:58Z","timestamp":1703767198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.2478\/jccm-2020-0010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,5,6]]},"published-print":{"date-parts":[[2020,5,6]]}},"alternative-id":["10.2478\/jccm-2020-0010"],"URL":"https:\/\/doi.org\/10.2478\/jccm-2020-0010","relation":{},"ISSN":["2393-1817"],"issn-type":[{"value":"2393-1817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}